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B I O P H Y S I C S
Molecular mechanism for kinesin-1 direct  
membrane recognition
Zuriñe Antón1, Johannes F. Weijman1, Christopher Williams2,3, Edmund R. R. Moody4, 
Judith Mantell1, Yan Y. Yip5†, Jessica A. Cross1,2, Tom A. Williams4, Roberto A. Steiner5,6,  
Matthew P. Crump2,3, Derek N. Woolfson1,2,3, Mark P. Dodding1*
The cargo-binding capabilities of cytoskeletal motor proteins have expanded during evolution through both gene 
duplication and alternative splicing. For the light chains of the kinesin-1 family of microtubule motors, this has 
resulted in an array of carboxyl-terminal domain sequences of unknown molecular function. Here, combining 
phylogenetic analyses with biophysical, biochemical, and cell biology approaches, we identify a highly conserved 
membrane-induced curvature-sensitive amphipathic helix within this region of a subset of long kinesin light-
chain paralogs and splice isoforms. This helix mediates the direct binding of kinesin-1 to lipid membranes. 
Membrane binding requires specific anionic phospholipids, and it contributes to kinesin-1–dependent lysosome 
positioning, a canonical activity that, until now, has been attributed exclusively the recognition of organelle- 
associated cargo adaptor proteins. This leads us to propose a protein-lipid coincidence detection framework for 
kinesin-1–mediated organelle transport.
INTRODUCTION
While ancestral reconstructions suggest that early eukaryotes were 
already capable of kinesin-mediated microtubule transport, the kinesin 
repertoire has been elaborated throughout eukaryotic evolution through 
gene duplication and alternative splicing (1, 2). How this complexity 
subsequently confers broader functional capacity often remains un-
clear. This question is particularly pertinent for the kinesin-1 family 
that uses a remarkably versatile cargo recognition mechanism to 
enable the binding and transport of protein and ribonuclear protein 
complexes, viruses, microtubules, and many different membrane- 
bound organelles (MBOs) (3–6). This mechanism comprises an inter-
linked and cooperative network of cargo binding and autoregulatory 
elements within the motor adenosine triphosphatase bearing kinesin 
heavy chains (KHCs) and kinesin light chains (KLCs) (7–9).
The number of KLC genes varies between species; humans and 
mice have four paralogous KLCs (KLC1 to KLC4) (10–19). KLC 
pairs combine with one of three KHC dimers (encoded by the 
KIF5A, -B, or -C paralogs) to form an array of kinesin-1 hetero-
tetramers with different cell and tissue expression profiles and 
cargo-binding properties (20–24). The physiological importance of 
kinesin-1 composition is underscored by a range of different neuro-
logical diseases that are reported to be contributed to or caused by 
dysregulation of particular KHCs and KLCs. These include loss 
of KLC4 function in hereditary spastic paraplegia; up-regulation 
of KLC1 isoform E (KLC1E) in Alzheimer’s disease (AD); and 
up-regulation of KLC2 in spastic paraplegia, optic atrophy, and 
neuropathy (SPOAN) syndrome (25–28).
KLCs recognize MBO-associated cargo adaptor proteins using 
their highly conserved tetratricopeptide repeat (KLCTPR) domains. 
Recent structural studies have revealed the molecular details of this 
motor-cargo interface that can engage both leucine-zipper and short 
linear peptide motif (SLiM) features in adaptor proteins. These 
adaptors act as a regulatory tether between motor and cargo that 
couples cargo binding with motor activity and transport (8, 29–33). 
KLC amino acid sequences mainly diverge in their C-terminal do-
mains (KLCCTD: defined here as any protein sequences after the end 
of KLCTPR). KLCCTDs help to direct MBO targeting (34–36) and 
enable the phosphorylation-dependent regulation of kinesin-1 
activity in axonal transport (37, 38). The molecular basis for these 
activities is not understood.
Here, we describe the discovery and characterization of an evo-
lutionarily conserved, membrane-induced, amphipathic helix (AH) 
within the C-terminal domains (CTDs) of a subset of long KLCs that 
mediates the direct phospholipid-dependent binding of kinesin-1 to 
membranes and facilitates the transport of lysosomes.
RESULTS
In silico sequence and structural analysis reveals an  
AH within the long KLCs
A comparison of KLCCTD primary sequences and their predicted 
secondary structures indicated the presence of a lone  helix within 
an otherwise unstructured domain of the long KLC1 splice isoforms 
(KLC1D and KLC1E, encoded by exon 16) and KLC2 and KLC4, but 
not the short KLC1, isoforms (KLC1A, KLC1B, KLC1C, KLC1F, 
and KLC1G) (Fig. 1, A and B). The predicted helix in KLC1D/E is 
also found in the KLC1I, KLC1J, KLC1K, KLC1M, KLC1N, and 
KLC1O variants that are not considered in the present study (16). 
Further characterization of this sequence suggested that the helix, if 
formed, would have a hydrophobic face and a net positively charged 
face (i.e., an AH) (Fig. 1C). A shorter sequence that retains some 
similar hydrophobic and charged amino acids encoded by exon 14 
(skipped in KLC1D/E) is found in KLC1B and KLC1C (Fig. 1B). 
Further complexity arises in the case of KLC3; a structure-based 
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alignment revealed that, unlike the other paralogs, KLC3TPR terminates 
within TPR5, and so it lacks the final sixth TPR (fig. S1). However, 
the predicted AH is still present after the truncated KLCTPR domain 
(Fig. 1C and fig. S1).
We identified the same AH feature in vertebrate (chicken, frog, 
and zebrafish) KLC orthologs (fig. S2). Kinesin-1 associates with 
membranes in sea urchins [Stronglyocentrotus purpuratus (SP)] (39), 
and we identified the AH within long KLC isoforms, SPKLC1 to 
Fig. 1. Long KLC paralogs and isoforms carry an amphipathic helix within their C-terminal domain. (A) Domain architecture of the KLCs. LFP, leucine-phenylalanine-proline. 
(B) Manually edited PROMALS3D-based alignment and JPred4 secondary structure predictions for the CTDs of mouse KLC1 to KLC4. Lengths are indicated from a con-
served post-KLCTPR QG(L/T)D sequence. H, helix; E, extended. (C) Visualization of the AH in KLC1 to KLC4 using HeliQuest and PyMOL.
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SPKLC3, but not the short SPKLC4 (fig. S2) (15). BLASTp searches 
of the National Center for Biotechnology Information (NCBI) 
nonredundant (nr) database indicated its presence in many other 
deuterostome KLCs (fig. S3A). The AH was not apparent in the rela-
tively short fly [Drosophila melanogaster; (19)] or worm [Caenorhabditis 
elegans; (18)] orthologs; this is despite the fact that their KLCs have 
very well-conserved KLCTPR domains that enables clear definition 
of the KLCCTD (fig. S2). Further analysis using HHpred failed to 
reveal any significant similarity (E value of <1) to any protein in these 
species (40). However, further database analysis and secondary struc-
ture prediction did identify closely related AH sequences in the 
KLCCTD of other protostomes, including Brachiopoda and Annelida, 
as well as nonbilaterian animals, including Cnidaria, Ctenophora, 
and Placozoa (fig. S3B), suggesting that the AH motif is evolution-
arily conserved.
Phylogenetic analysis indicates that the AH is an ancestral 
KLC feature
A KLC phylogeny (fig. S4) indicated that the four paralogous KLC 
protein coding genes of human and mouse arose from gene dupli-
cations on the gnathostome stem, with KLC1 to KLC4 being repre-
sented in the various classes that make up Eugnathostomata: 
Mammalia, Eureptillia, Amphibia, Actinopterygii, and Chondrichthyes. 
The multiple KLC homologs of Petromyzon appear to be the result 
of independent, lineage-specific duplications, with the same mech-
anism resulting in C. elegans klc-1 and klc-2. The presence of clear KLC 
orthologs in animals and choanoflagellates, but not in more distant 
opisthokonts, indicates that the KLC gene originated in their common 
choanozoan ancestor. Paralogs of KLC are present in some fungi, 
Viridiplantae, and members of the Stramenopila, Alveolata, and Rhizaria 
clade of eukaryotes. As for D. melanogaster and C. elegans, the AH 
region was not detected in sequences of the wider Ecdysozoa. This 
can be explained by secondary loss because the AH motif is present in 
nonbilaterian holozoan sequences, including choanoflagellates. The 
onset of alternative splicing as a means of producing AH-containing 
and AH-lacking protein variants in mice and humans likely arose 
on the agnathan stem lineage because the deep-branching agnathan 
Petromyzon (sea lamprey) has isoforms displaying the short and 
long form, whereas more distantly related genomes do not.
Together, these data show that the KLC protein family can be 
divided into short forms that lack, and long forms that carry, an 
evolutionarily well-conserved ≈20 amino acid predicted AH 
within their CTD. In general, amino acids on the hydrophobic face 
are highly conserved, whereas the abundance, position, and polarity 
of charges vary on the hydrophilic face but retain the overall basicity. 
Serine residues occur frequently, but their number and position vary 
(Fig. 1C and figs. S2 and S3).
The AH peptide adopts a helical conformation 
in the presence of model membranes
A synthetic peptide encompassing this sequence from KLC1D/E 
was analyzed in vitro using circular dichroism (CD) spectroscopy 
(Fig. 2A). In aqueous solution, the KLC1D/E peptide was unstruc-
tured. However, in the presence of the zwitterionic membrane 
mimetic dodecylphosphocholine (DPC) micelles, the CD spectrum 
changed to one characteristic of a highly folded (71% helicity)  helix 
(Fig. 2A). To test this further, a control peptide with two aliphatic 
residues replaced by proline (IL/PP KLC1D/E) was designed to 
prevent helical folding. This gave a CD spectrum expected for a 
random coil, both in the absence and presence of DPC micelles 
(Fig. 2A). The helical folding of the parent KLC1D/E peptide was 
not induced with the nonionic detergents n-dodecyl -d-maltoside 
(DDM), octyl -d-glucopyranoside (OG), or the zwitterionic deter-
gent lauryldimethylamine oxide (LDAO), indicating that specific 
electrostatic protein-lipid interactions may be important for AH 
folding (fig. S5A).
Next, we used nuclear magnetic resonance (NMR) to examine con-
formational changes in the peptide in more detail (Fig. 2, B and C, 
and fig. S5, B and C). The one-dimensional (1D) 1H NMR spectrum 
of the peptide in buffer was typical of a random coil with very little 
dispersion in either the amide or methyl regions (fig. S5B). However, 
upon titration with perdeuterated DPC, the peptide chemical shifts 
became sharper and more dispersed, saturating at around 0.7% DPC. 
This was particularly evident in the amide region of spectrum indic-
ative of folding in the presence of DPC (fig. S5B). This was confirmed 
by collecting 1H-15N heteronuclear single-quantum coherence (HSQC) 
datasets at natural 15N abundance (Fig. 2B). In the presence of 
deuterated DPC, the 1H-1H nuclear Overhauser effect spectroscopy 
(NOESY) and total correlation spectroscopy (TOCSY) spectra of the 
peptide gave sufficiently dispersed HN and H resonances to allow a 
NOE-based sequential assignment of the spectra (Fig. 2B). Backbone 
NH resonances could be assigned for ≈80% of the peptide with 
missing assignments at the N terminus and in the central R11/R12 
region (Fig. 2B). Analysis of the 2D NOESY spectra identified a 
number of dNN(i,i + 1) and dN(i,i + 1) throughout the peptide 
backbone along with several dN(i,i + 3) and dN(i,i + 4) NOE cor-
relations. These are diagnostic of -helical conformation (Fig. 2C). 
In particular, a number dN(i,i + 3) and dN(i,i + 4) NOEs between 
residues S13 and K20 indicated clearly that this region is an  helix. 
Although there were distinct dNN(i,i + 1), dN(i,i + 1), and dN(i,i + 3) 
NOEs in the N terminus of the peptide, this region was less well 
defined due to a greater overlap in the NH-H region of the 2D NOESY 
spectra. In addition to the NOE analysis, the 13C/C and H back-
bone chemical shifts for the assigned residues were extracted using 
a natural abundance 1H-13C HSQC. The subsequent chemical shift 
index analysis of the chemical shifts for the DPC-bound peptide were 
again consistent with an  helix for two stretches of residues, K5-I10 
and S13-K20, as observed in the NOESY spectra (Fig. 2C).
The AH mediates KLCCTD binding to lipid membranes
To evaluate the capacity of KLCCTD to bind membranes, we assembled 
liposomes [small unilamellar vesicle (SUV) and large unilamellar 
vesicle (LUV)] from Folch fraction I brain lipids and analyzed the 
capacity of KLCCTDs (fig. S6A) to associate with them using cosedi-
mentation assays. We focused on the KLC1 paralog for these 
liposome-binding assays because of the availability of natural isoform 
controls. Purified recombinant KLC1ECTD that contains the predicted 
AH (long), but not KLC1BCTD (short), bound to LUVs in a liposome 
concentration–dependent manner (Fig. 3, A and B). Binding of 
KLC1ECTD to SUVs was significantly greater than to LUVs, indicating 
that the interaction is sensitive to membrane curvature (Fig. 3B). In 
a separate experiment, as expected, KLC1ACTD also failed to associate 
with membranes (fig. S6B). A single helix-disrupting proline muta-
tion (I560P in full-length protein; I/P mutant) in the hydrophobic 
face of KLC1ECTD AH was sufficient to eliminate any detectable 
membrane interaction (Fig. 3, C and D). Furthermore, amine cross- 
linking by bis(sulfosuccinimidyl)suberate (BS3), in the absence or 
presence of LUVs and SUVs (Fig. 3E), resulted in the AH- and 
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liposome-dependent formation of KLC1ECTD oligomers with electro-
phoretic mobility corresponding to dimers, trimers, and tetramers, 
as well as higher-order assemblies. Membranes were also remodeled 
because analysis of (non–cross-linked) samples by cryo–electron 
microscopy revealed extensive AH-dependent membrane bending 
and vesicle clustering, as well as the accumulation of small vesicles 
(Fig. 3F). We concluded that KLC1ECTD binds directly to membranes, 
and this interaction requires the AH.
Long KLCCTDs membrane binding is dependent on specific 
anionic phospholipids
Liposomes of defined composition were prepared from pure lipids. 
No binding was observed with either wild-type (WT) or the helix- 
disrupting mutant KLC1ECTD upon incubation with liposomes 
consisting of PC, PC:PE (7:3), or PC:PE:PS (5:3:2) (Fig. 4A) (where 
PC is phosphatidylcholine, PE is phosphatidylethanolamine, and 
PS is phosphatidylserine), suggesting that an additional component 
is required. We considered phosphatidic acid (PA) to be a good 
candidate because KLC1 (along with KIF5B) has been identified 
recently in a proteomic screen for PA-binding proteins (41). WT 
KLC1ECTD, but not the helix-disrupting mutant, bound to PC:PE:PA 
(5:3:2) liposomes, although to a slightly lesser extent than to the Folch 
fraction liposomes (Fig. 4A). Moreover, KLC1BCTD showed no de-
tectable binding to PA-containing liposomes (fig. S6C).
Together, these data above show that KLC1ECTD binds to PA in 
an AH-dependent manner. However, as PA only comprises a small 
component of Folch fraction I liposomes, and even at 20% as used 
in our pure lipid assays was insufficient to match the degree of binding, 
we considered the possibility that KLC1ECTD has a broader capacity 
for acidic phospholipid recognition. Consistent with this, long 
KLCCTDs (KLC1D, KLC1E, and KLC2) bound to phosphoinositides 
on membrane strips with some preference for PI(5)P and PI(3,5)P2; 
moderate association with PI(3)P, PI(4)P, and PI(4,5)P2; very little 
binding to PI(3,4)P2 and PI(3,4,5)P3; and no detectable interaction 
with PI (Fig. 4B). The short variants lacking the AH (KLC1A/B/CCTD) 
did not interact with any phosphoinositide (fig. S6D). As these strips 
present the lipid outside of the context of a bilayer, we performed 
liposome-binding assays with one of the top binding candidates, 
PI(5)P (Fig. 4C). Consistent with the PIP array data, KLC1ECTD was 
also capable of interacting with PI(5)P, but not PI, although to a 
lesser extent than with the same amount of PA (Fig. 4C). Again, the 
helix-disrupting mutant showed no binding (Fig. 4C). We extended 
Fig. 2. The AH peptide folds into a helix in the presence of model membranes. (A) Peptide sequences and their CD spectra in the absence or presence of 0.35% DPC. 
(B) Overlaid 15N HSQCs of the unbound (black) and DPC-bound (red with assignments) peptides. ppm, parts per million. (C) NOE/chemical shift index (CSI) plot of the 
DPC-bound peptide sequence.
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Fig. 3. The AH is required for KLC1ECTD binding to liposomes. (A) Representation of the His-tagged KLC1B/ECTD constructs. (B) Cosedimentation analysis of His-KLC1B/
ECTD with Folch fraction I LUV or SUV. Samples were analyzed by SDS-PAGE/Coomassie (top) and quantified by densitometry (bottom). Means ± SEM of at least three ex-
periments. **P < 0.01 and ***P < 0.001 compared to the sample without liposomes or as indicated in the graph. (C) Sequence comparison and visualization of the AH in 
the I560P KLC1ECTD mutant. (D) Cosedimentation analysis of WT or I/P His-KLC1ECTD with Folch fraction I LUV or SUV. Means ± SEM of at least three experiments. **P < 0.01 
and ***P < 0.001 compared to the sample without liposomes or as indicated in the graph. (E) BS3 cross-linking assay showing oligomers of WT, but not I/P mutant His-KLC1ECTD 
upon incubation with Folch fraction I LUV or SUV. (F) Cryo–electron microscopy observation of Folch fraction I LUV in the absence or presence of WT or I/P mutant 
KLC1ECTD. Scale bar, 200 nm.







Antón et al., Sci. Adv. 2021; 7 : eabg6636     28 July 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
6 of 14
Fig. 4. Long KLCCTDs bind to specific anionic phospholipids. (A) Cosedimentation analysis of WT or I/P His-KLC1ECTD incubated with PC, PC:PE (7:3), PC:PE:PS (5:3:2), 
PC:PE:PA (5:3:2), or Folch fraction I LUV. (B) Binding of the indicated long KLCCTDs to phosphoinositides in a protein lipid overlay assay. Quantitation is provided at the 50 pmol 
per spot. a.u., arbitrary units. (C) Cosedimentation analysis of WT or I/P His-KLC1ECTD incubated with PC:PE:PI, PC:PE:PI(5)P, or PC:PE:PA (5:3:2) LUV. (D) Cosedimentation 
analysis of WT His-KLC1ECTD incubated with PC:PE:PI(3)P, PC:PE:PI(4)P, PC:PE:PI(5)P, or PC:PE:PI (5:3:2) LUV. Means ± SEM of at least three experiments. *P < 0.05, **P < 0.01, 
and ***P < 0.001 compared to the sample without liposomes or as indicated in the graph. (E) Immunofluorescence analysis (top) showing localization of GFP, GFP-KLC1ECTD, 
and GFP-CC-tet-KLC1ECTD. Golgi is stained with anti-giantin antibody. Representative Pearson’s correlation from one experiment and ≈40 cells (bottom). (F) BS3 cross-linking 
assay showing monomeric or tetrameric expression of KLC1ECTD in lysates of HeLa cells transfected with GFP-KLC1ECTD or GFP-CC-tet-KLC1ECTD. (G) GFP-CC-tet-KLC1ECTD-
giantin colocalization in cells treated with the PIKfyve inhibitor YM201636 as indicated (top). Representative Pearson’s correlation from one experiment and ≈40 cells 
(bottom). Means ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001. Scale bars, 20 m. DAPI, 4′,6-diamidino-2-phenylindole.







Antón et al., Sci. Adv. 2021; 7 : eabg6636     28 July 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
7 of 14
this analysis to PI(3)P and PI(4)P. Consistent with the PIP array data, 
KLC1CTD bound to PI(3)P, PI(4)P, and PI(5)P; however, the prefer-
ence for PI(5)P was not apparent (Fig. 4D). We concluded that the 
AH is essential for KLC1CTD-mediated membrane interaction, it 
shows a requirement and some selectivity for specific anionic phos-
pholipids, and those properties extend to the closely related sequences 
in KLC2CTD.
To explore these interactions in cells, we compared the subcellular 
localization of green fluorescent protein (GFP) and GFP-KLC1ECTD 
in HeLa cells (Fig. 4E). Whereas GFP was diffusely distributed 
throughout the cytoplasm and nucleus, GFP-KLC1ECTD signal was 
slightly enriched in the perinuclear region. It partially colocalized 
with antibody staining for the Golgi marker giantin (Fig. 4E). We 
anticipated that the forced oligomerization of GFP-KLC1ECTD might 
increase avidity and enhance target membrane association. To test 
this, we introduced the sequence for a de novo–designed coiled-coil 
tetramer between GFP and KLC1ECTD (GFP-CC-tet-KLC1ECTD) (42). 
The mobility of the fusion proteins from HeLa cell lysates was mon-
itored by SDS–polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western blotting (Fig. 4F). Confirming the functionality of the 
coiled-coil sequence, a band shift to the expected molecular weight 
of an SDS-resistant tetramer was only observed with the GFP-CC-
tet-KLC1ECTD after BS3 treatment (Fig. 4F). As predicted, the 
perinuclear membrane association became more pronounced with 
GFP-CC-tet-KLC1ECTD, as determined by the giantin colocalization 
analysis of the GFP signal (Fig. 4E). This was AH dependent because 
incorporation of the I/P AH mutant in GFP-CC-tet-KLC1ECTD or 
its truncation in GFP-CC-tet-KLC1ACTD resulted in fluorescence 
signal diffusely distributed throughout the cytoplasm and nucleus 
(fig. S7). Although the GFP-CC-tet-KLC1ECTD fluorescence signal 
overlapped with giantin, there was clearly recruitment to other peri-
nuclear compartments (Fig. 4E), suggesting that KLC1ECTD-organelle 
recruitment is not specific for the Golgi and appears consistent 
with the quite broad acidic phospholipid-binding properties ob-
served in vitro.
However, as our vitro analysis showed that KLCCTDs are capable 
of binding to PI(5)P and PI(3,5)P2, and PIKfyve inhibition modifies 
the motility of lysosomes, a canonical kinesin-1 cargo (43, 44), we 
used the PIKfyve kinase inhibitor YM201636 to reduce 5′ phos-
phorylation. This led to the redistribution of GFP-CC-tet-KLC1ECTD 
to more dispersed puncta (Fig. 4G) and a time- and inhibitor 
concentration–dependent reduction in the colocalization of GFP-
CC-tet-KLC1ECTD with giantin. Thus, consistent with the membrane- 
binding properties observed in vitro using recombinant protein 
(Fig. 4, A to D), KLC1ECTD localization is sensitive to membrane 
phosphoinositide composition in cells.
Long KLCCTD-dependent membrane association of kinesin-1 
is phosphoinositide sensitive and is important for  
lysosome positioning
To determine how membrane binding by isolated KLCCTD extends 
to the complete tetrameric holoenzyme, we focused on endogenously 
expressed kinesin-1 in biochemical assays, first seeking to establish 
the KLC1 and KLC2 expression profile in HeLa cells. These were 
transfected with plasmids to express full-length hemagglutinin (HA)–
tagged KLC1A, KLC1E, and KLC2 and compared to nontransfected 
cells by SDS-PAGE and Western blot analysis. An anti-HA antibody 
detected the overexpressed proteins, and, consistent with their 
molecular weights, HA-KLC1E and HA-KLC2 migrated more slowly 
than HA-KLC1A (Fig. 5A). Anti-KLC1 antibodies detected both 
overexpressed isoforms of KLC1 with similar efficiency, but not 
KLC2, and also a slightly faster migrating band in all samples that 
was confirmed to be an endogenous KLC1 isoform by short inter-
fering RNA (siRNA) depletion of KLC1 (Fig. 5A). Similarly, anti- 
KLC2 antibodies specifically detected overexpressed HA-KLC2, but 
not HA-KLC1, and a slightly faster migrating band that was con-
firmed as endogenous KLC2 by siRNA knockdown (Fig. 5A). 
Together, these data indicate that most KLC1 in HeLa cells is a short 
isoform. In addition, the approximately equal expression of the 
HA-tagged proteins and difference in band intensity between 
endogenous and overexpressed proteins for the KLC1- and KLC2- 
specific antibodies led us to conclude that HeLa cells express similar 
amounts of KLC1 and KLC2 (roughly 40:60).
To compare the localization of the endogenous KLC paralogs, 
HeLa cell extracts were fractionated. As well as in the cytosolic frac-
tion (containing -tubulin), KLC2 was found in the membrane 
(containing Rab6 and Rab7) and nuclear (containing histone H3) 
fractions (Fig. 5B). In contrast, the shorter KLC1 was almost exclu-
sively found in the cytosolic fraction (very weak bands in nuclear 
fraction on long exposure) and not at all in the membrane fraction, 
consistent with a specific role for the long KLCs membrane associ-
ation. The major KHC paralog in HeLa, KIF5B, was found in all 
three fractions (Fig. 5B). Confirming a role for phosphoinositides in 
directing membrane association, treatment of cells with PIKfyve 
inhibitor reduced the amount KLC2 and KIF5B in the membrane 
and nuclear fractions (Fig. 5C).
To ask whether KLCCTD is necessary and sufficient for direct 
membrane targeting of kinesin-1, KHC-KLC1B, KHC-KLC1E, and 
KHC-KLC2 complexes were isolated from 293T cells by HaloTag 
purification and size exclusion chromatography (9). Consistent with 
a direct role in membrane binding of the holoenzyme, tetramers 
containing the long KLC1E or KLC2 sequences bound significantly 
better to Folch fraction I liposomes in cosedimentation assays 
compared to the short KLC1B isoform (Fig. 5D). In a separate 
experiment, I/P mutant KHC-KLC1E significantly reduced lipo-
some binding (Fig. 5E), confirming a role for the AH in tetramer- 
membrane association.
To explore the functional role for the AH and its relationship to 
KLCTPR-mediated SLiM interactions, we turned to a lysosomal trans-
port model. Lysosome distribution in HeLa is controlled by kinesin-1 
through a well-defined cargo adaptor axis, BORC-Arl8-SKIP-KLC2- 
KIF5B, where SifA and kinesin interacting protein (SKIP) acts 
as the cargo adaptor protein, binding KLCTPR and KHC using the 
W-acidic class of SLiM (29, 45–50). siRNA knockdown of KLC2 caused 
reduction in the proportion of peripheral lysosomes compared to 
control cells (Fig.  6,  A  and  B). A typical WT distribution profile 
characterized by many lysosomes in the cytoplasm outside the 
perinuclear region and accumulations at the cell periphery could be 
restored by expression of WT KLC2, but not KLC2, with a helix- 
disrupting mutation (L550P, equivalent to I560P in KLC1E). This 
confirms a role for the AH-membrane binding in kinesin-1–mediated 
lysosome positioning (Fig. 6, C and D). Similarly, expression of the 
long KLC1E, but not the short KLC1A, isoform restored cytoplasmic 
and peripheral lysosome accumulations (Fig. 6, C and D). Further-
more, the defect in transport associated with the L550P mutation 
was comparable to that observed for a tryptophan-acidic class 
SLiM-binding KLC2 mutant (N287L) (Fig.  6E). Together, these 
data indicate that the long AH-containing paralogs have some 
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Fig. 5. Membrane association of kinesin-1 is mediated by KLCCTD and is phosphoinositide sensitive. (A) KLC1/2 expression in HeLa cells transfected with HA-KLC1A/1E/2 
or nontransfected cells (left) or after siRNA knockdown of KLC1/2 (right) was analyzed by Western blot. (B) Fractionation and Western blot analysis of endogenous KIF5B 
and KLC1/2. (C) Fractionation analysis of cells treated with dimethyl sulfoxide (DMSO) or PIKfyve inhibitor YM201636 (10 M, 4 hours). Means ± SEM of at least three experi-
ments. *P < 0.05, **P < 0.01, and ***P < 0.001 compared to the sample treated with DMSO. (D) Cosedimentation assay and analysis by SDS-PAGE/Commassie staining using 
purified KHC-KLC1B/1E/2 and Folch fraction I LUV. (E) Cosedimentation assay and analysis by SDS-PAGE/Commassie staining using purified KHC-KLC1E or –I/P KLC1E and 
Folch fraction I LUV. Means ± SEM of at least three experiments. **P < 0.01 and ***P < 0.001 compared to the sample without liposomes or as indicated in the graphs.
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Fig. 6. Long KLCs are required for kinesin-1–mediated lysosome positioning. (A) Western blot analysis of KLC2 expression in HeLa cells after siRNA knockdown of 
KLC2. (B) Lysosome distribution in control or KLC2 knockdown cells. Lysosome dispersion was determined by measuring perinuclear and whole-cell LAMP1 signal fluo-
rescence. Means ± SEM of at least three experiments. ***P < 0.001. (C) KLC1/2 expression in KLC2 knockdown HeLa cells transfected with HA-KLC1A/1E/2/L550P 2 was 
analyzed by Western blot. (D) Lysosome distribution in KLC2 knockdown cells transfected with HA-KLC1A/1E/2/L550P 2. Means ± SEM with samples pooled from three 
independent experiments. *P < 0.05. (E) Lysosome distribution in KLC2 knockdown cells transfected with HA-KLC2 or N287L/L550P variants. Means ± SEM with samples 
pooled from three independent experiments. ***P < 0.001. (F) Model showing representation of kinesin-1 cargo membrane association by the KLCs. The membrane-induced 
helical folding and membrane remodeling capacity of the KLCCTD helix are also represented. ns, not significant.







Antón et al., Sci. Adv. 2021; 7 : eabg6636     28 July 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
10 of 14
functional redundancy in lysosome transport (consistent with their 
shared ancestry) and that AH-membrane binding is as important 
as SLiM-mediated cargo adaptor interactions.
DISCUSSION
The mechanistic basis for the critical role that the KLCCTDs play in 
organelle transport has proved elusive. This is intimately linked with 
the question of why, particularly in vertebrates, the evolution of 
intracellular transport has favored gene duplication and alternative 
splicing events that have resulted in so many KLCs that differ mainly 
in their CTD. The identification here of a membrane-induced AH 
within a subset of long KLCCTDs provides an explanation, showing 
that the role of these sequences is to confer a direct membrane binding 
capacity on the motor complex. Functionally, this brings the kinesin-1 
family in line with the kinesin-3 family members that also incorporate 
classical membrane binding structures and play key roles in vesicle 
and organelle transport. However, in the case of kinesin-3, these are 
globular Pleckstrin homology and Phox homology domains (51). 
To the best of our knowledge, this is the first report of a membrane- 
binding/induced AH, a feature more typically associated with small 
guanosine triphosphatases, vesicular coats, and their accessory pro-
teins, being used directly by a microtubule motor protein. The po-
tential to attribute a relative increase in KLC1E or KLC2 expression 
to modification of the direct membrane properties of the kinesin-1 
pool offers a pathway to understanding their reported roles in AD 
and SPOAN syndrome, respectively (25, 28).
Given the well-established role of cargo adaptor proteins in motor 
recruitment and activation (7, 8), including at the lysosome (29, 45, 47), 
we favor a coat-like coincidence detection framework to explain our 
observations (Fig. 6F). In this model, cargo adaptor proteins bind to 
KLCTPR and membranes to KLCCTD. It will be important to sequence 
these protein and lipid interactions correctly. Previous work has 
indicated that the KLCTPR-adaptor binding gates access to cargo- 
binding features of the KHC tail (46). It seems reasonable to suggest 
that the KLCCTD-membrane interaction may function higher in this 
hierarchy to locally concentrate kinesin-1 at sites where it is avail-
able to engage cargo adaptor proteins. The nature of the final trans-
port competent assembly will depend on the adaptor system because 
kinesin-1 cargo adaptors can be integral or peripheral membrane 
proteins (8). The complex role of the KHC tail merits further study. 
Overlapping, mostly basic, coiled-coil–containing KHC sequences 
have been shown to functionally bind to membranes, adaptor 
proteins, and microtubules. In several cases, there is evidence of 
sequence specificity; in others, binding may be mostly electrostatic 
(41, 46, 52–59). The direct, AH-dependent binding of the KLCs 
to membranes containing specific anionic phospholipids shown 
here fits well within a broader model of cooperative sequence/
structure specific and electrostatic elements effecting KHC- and 
KLC-dependent cargo recognition and motor activation for diverse 
transport functions.
It is likely that phosphorylation will emerge as a key KLC 
membrane-binding regulator; CKII and GSK3 have been shown to 
phosphorylate KLC2CTD to negatively regulate axonal transport, and 
a serine residue within AH itself (S542 in mouse) as well as another 
at S579 in KLC2CTD are phosphorylated by AMP-activated protein 
kinase to inhibit axonal PI3K trafficking (37, 38). We posit that se-
quence differences between the long KLCCTDs could offer the kinesin-1 
family different sensitivity to particular kinases and phosphatases. 
A report of binding of 14-3-3 proteins to phosphorylated KL-
C2CTD suggests that an AH/CTD-sequestration hypothesis is also 
worth considering as another level of regulation (60).
What of the short KLCs? Our phylogenetic analysis suggests that 
membrane binding by the AH is an ancestral animal KLC feature. 
Counterintuitively, it appears that the loss of the AH rather than its 
acquisition may be associated with diversification of function. 
Previous reports have implicated KLC1B and KLC1C isoforms in 
rough endoplasmic reticulum and mitochondrial targeting despite 
lacking the exon 16 sequence encoded by the AH (16, 34, 35). How-
ever, both isoforms share some sequences with limited homology to 
the second half of the AH (encoded by exon 14). Although helical 
properties of this 10–amino acid sequence were not confidently 
predicted by our in silico analysis, if folded, the resulting structure 
would be amphipathic. Whether it has a membrane/lipid-binding 
capacity that was not detected in our assays is clearly worth further 
investigation. More generally, given their de facto positioning at the 
motor-organelle interface, there is a good case for a wider explora-
tion of the membrane-binding properties of the long and short 
KLCCTDs throughout the wider KLC family. Specifically, it will be 
important to consider why the AH sequence was lost (relatively recently 
in evolutionary terms) in Ecdysozoa, including D. melanogaster and 
C. elegans, and if KLC intrinsic or extrinsic compensatory mecha-
nisms have emerged. In D. melanogaster, the single kinesin-1 (one 
KHC gene and one KLC gene) carries out diverse activities including 
microtubule-microtubule sliding, RNA transport, and organelle 
transport (6, 61, 62). It will be interesting to ask whether the range 
of KLC transcripts and CTD sequences in vertebrates are an example 
of functional diversity created and maintained by gene duplication 
and alternative splicing, where short KLC1 isoforms might be pri-
marily used for the transport of nonmembranous cargos such as 
microtubules or ribonuclear protein complexes (63).
In conclusion, the identification of an AH in the cargo-binding 
mechanism of the kinesin-1 motor should lead to a step change in 
the view of how the family is classified, and cargoes are recognized 
by this central player in intracellular transport. It points to a 
direct role for membrane biology in KLC-dependent vesicle and 




DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), bovine liver 
phosphatidylinositol (PI), brain PS, and egg PA were purchased from 
Avanti Polar Lipids. PI 3-phosphate diC16 [PI(3)P], PI 4-phosphate 
diC16 [PI(4)P], and PI 5-phosphate diC16 [PI(5)P] were obtained 
from Echelon Biosciences. Folch fraction I and egg PC were purchased 
from Sigma-Aldrich. YM201636 PIKfyve inhibitor was purchased 
from Cayman Chemical. A cell fractionation kit was obtained from 
Cell Signaling Technology. Nontargeting control siRNA was obtained 
from Horizon Discovery, and human KLC1/2 siRNAs were from Santa 
Cruz Biotechnology. The following primary antibodies were used: 
horseradish peroxidase (HRP)–conjugated anti-His6 (71841, Novagen), 
anti-GFP for immunoblotting (3E1, Roche), anti-actin (AC-74, Sigma- 
Aldrich), anti–-tubulin (AA2, Sigma- Aldrich), anti–histone H3 (Abcam), 
anti-giantin (PRB-114C, Covance), anti-HA (HA-7, Sigma-Aldrich), anti- 
KLC1 ([EPR12441(B)], Abcam), anti-KLC2 (Abcam), anti-KIF5B 
(Abcam), anti-LAMP1 (lysosome-associated membrane protein 1) 
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(D2D11, Cell Signaling Technology), anti-Rab7 (D95F2, Cell Signaling 
Technology), and anti-Rab6 (D37C7, Cell Signaling Technology). 
Alexa 568– and Alexa 633–conjugated anti-mouse or anti-rabbit 
secondary antibodies were from Thermo Fisher Scientific.
Peptides and plasmids
KLC1D/E synthetic peptides used for CD or NMR measurements 
were purchased from GenScript (>98% purity). Sequences were as 
follows: WT KLC1D/E, GSFSKLRASIRRSSEKLVRKLKGG; IL/PP 
KLC1D/E, GSFSKLRASPRRSSEKPVRKLKGG. Peptides were dis-
solved in water and stored at −20°C until use.
KLC1 isoforms were generated by synthetic DNA synthesis and 
restriction enzyme cloning using a mouse KLC1A clone as a start-
ing point. KLC1A coding sequence corresponding to NM_008450.2 
was in vector CB6-HA (N-terminal HA epitope tag, mammalian 
expression) flanked Eco RI and Bam HI restriction enzyme sites. A 
unique Nhe I restriction endonuclease site was added to the KLC1A 
sequence by site-directed mutagenesis at 1162 to 1167 by introducing 
a silent GCCTCC to GCTAGC mutation. This encodes an Ala-Ser 
sequence within the TPR domain. As the KLC1 isoforms only differ 
at the C terminus of the protein, this allowed the synthesis of a series 
of DNAs (GenScript) that could then be inserted between the newly 
created Nhe I site and the existing C-terminal Eco RI site. These 
sequences were identical to NM_001025358.2 → NP_001020529.2 
for KLC1B, NM_001025359.2 → NP_001020530.2 for KLC1C, 
NM_001025360.2 → NP_001020531.2 for KLC1D, and NM_001025361.2 → 
NP_001020532.2 for KLC1E, with the exception of KLC1D/E where 
an unwanted Nhe I site in the sequence encoding the CTD was 
removed before synthesis by introducing a silent mutation. For 
expression of the CTDs in bacteria, the DNAs encoding the CTD 
sequence commencing at Q496 (of QGLD sequence) were amplified 
by polymerase chain reaction (PCR) and subcloned into the Nde I/
Xho I sites of pET28a. The KLC2 sequence used in this study corre-
sponded to NM_008451.3 → NP_032477.2 (annotated KLC2 iso-
form 1 in the NCBI database) and was cloned into the CB6-HA 
vector using Not I and Eco RI restriction endonuclease sites. The 
CTD sequence was amplified from Q481 of QGLD sequence and sub-
cloned into pET28a as for KLC1 CTDs. The I560P helix disrupting 
KLC1E mutant was constructed by PCR-based site-directed 
mutagenesis using the following primers: forward, 5′-CAAACTC-
CGGGCTTCCCCTAGACGCAGCAGTGAG-3′; reverse, 5′-CTCACT-
GCTGCGTCTAGGGGAAGCCCGGAGTTTG-3′. The L550P 
helix-disrupting KLC2 mutant was constructed by PCR-based 
site-directed mutagenesis using the following primers: forward, 
5′-GCTCCGGGATGCTCCGAGACGCAGCAGTGAG-3′; reverse, 
5′-CTCACTGCTGCGTCTCGGAGCATCCCGGAGC-3′. GFP-
tagged KLC1ECTD was cloned from KLC1ECTD complementary 
DNA (cDNA) into a cytomegalovirus-driven expression vector 
(CB6-GFP) for expression in mammalian cells. For the expression 
of GFP-CC-tet-KLC1E/ACTD, cDNAs encompassing a de novo–
designed tetrameric coiled coil (39) and KLC1E/ACTD were synthe-
sized by Eurofins Genomics (pEX-A128 vector) and subcloned 
into CB6-GFP. The coiled-coil amino acid sequence was GELAA-
IKQELAAIKKELAAIKWELAAIKQ. The I560P helix-disrupting 
GFP-CC-tet-KLC1ECTD mutant was constructed by PCR-based 
site-directed mutagenesis using the following primers: forward, 
5′-CCAAACTTCGCGCTAGTCCACGGAGAAGTTCCGAG-3′; 
reverse, 5′-CTCGGAACTTCTCCGTGGACTAGCGCGAAGTTTGG-3′. 
All plasmids were verified by DNA sequencing.
Bacterial protein expression and purification
His-tagged KLCCTDs were expressed in Escherichia coli BL21(DE3) 
cells. Single colonies were picked and grown at 37°C overnight. 
Small-scale overnight bacterial cultures were used to inoculate two 
1-liter cultures that were incubated at 37°C until they reached an 
optical density at 600 nm of 0.6 to 0.8. The temperature was then 
lowered to 16°C, and protein synthesis was induced by the addition 
of 300 M isopropyl b-d-1-thiogalactopyranoside for 16 hours. Cells 
were harvested by centrifugation at 4000g for 30 min at 4°C and 
resuspended in 25 mM Hepes buffer (pH 7.4), 500 mM NaCl, 20 mM 
imidazole, and 5 mM -mercaptoethanol supplemented with protease 
inhibitor cocktail (Roche). Cell lysis was accomplished by sonication. 
Insoluble material was sedimented by centrifugation at 13,500g for 
30 min at 4°C before loading on His-trap FF columns (GE Healthcare) 
preequilibrated with lysis buffer. Proteins were eluted with an 
imidazole gradient and fractions containing the target protein 
collected using an AKTA Prime system (GE Life Sciences). Protein 
quality was analyzed by Coomassie gel analysis. Protein concentration 
was typically determined by band densitometry using a bovine 
serum albumin (BSA) standard curve due to the low molar extinc-
tion coefficient of the proteins. Proteins were snap-frozen and 
stored at −80°C.
Purification of HaloTag protein from  
mammalian cells
The day before transfection, 5 15-cm dishes were seeded with 4.5 × 
106 293T cells. These were transfected with 20 g of KHC and KLC 
expression plasmid (KIF5C/KLC2-TEV-Halo, HA-KLC1B/KLC1E/I/
PKLC1E/KIF5C) using the ProFection Mammalian Transfection 
System (Promega) as per the manufacturer’s instructions. Cells 
were left to express the proteins for 48 hours. Cells were then 
washed with phosphate-buffered saline (PBS) and gently scrapped 
in 2.5 ml of lysis buffer [50 mM tris (pH 7.5), 150 mM NaCl, 1 mM 
dithiothreitol (DTT), 1% Triton X-100, 0.1% sodium deoxycholate, 
1 mM MgCl2, and 0.1 mM adenosine 5′-diphosphate (ADP) sup-
plemented with protease inhibitor cocktail (Promega)]. Cells were 
placed on a rocker for 15 min at room temperature before being 
diluted in three volumes of Halo buffer [50 mM Hepes (pH 7.5), 
150 mM NaCl, 1 mM DTT, 0.005% IGEPAL CA-630, 1 mM MgCl2, 
and 0.1 mM ADP]. The lysate was sonicated for 2 min, 30 s, then 
pulse for 5 s on, and 10 s off, at 40% amplitude (Vibra Sonics). 
Insoluble material was pelleted by centrifugation at 10,000g for 
30 min at 4°C. The soluble fraction was incubated with 2.5 ml of 
HaloLink resin slurry (Promega, preequilibrated in Halo buffer) 
and allowed to incubate on a roller for 90 min at room temperature. 
Resin was washed in batch by three repeated rounds of centrifuga-
tion (1500g, 5 min, 4°C) and resuspension in Halo buffer. After the 
final wash, liquid was removed as much as possible, and HaloTEV 
(Tobacco Etch Virus) protease (300 units, Promega) was added to 
liberate protein. TEV cleavage proceeded for 60 min at room tem-
perature. The soluble material was separated from the resin by use 
of a spin filter (Thermo Fisher Scientific) and centrifugation (5000g, 
5 min, 4°C). Insoluble material was removed by centrifugation 
(20,000g, 5 min, 4°C), and the sample was further purified by size 
exclusion chromatography on a Superdex 200 Increase (10/300) 
column (GE) preequilibrated in 20 mM Hepes (pH 7.5), 150 mM NaCl, 
1 mM MgCl2, 0.1 mM ADP, and 5 mM -mercaptoethanol. The 
resulting purified protein was snap-frozen in liquid nitrogen and 
stored at −80°C until use.
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Circular dichroism
CD spectra were recorded with a 1-mm path length cell at 20°C 
using a Jasco 815 spectropolarimeter (Jasco, MD, USA) fitted with 
a Peltier temperature controller, and baseline-corrected. KLC1D/E 
synthetic peptides were diluted at 57 mM in PBS buffer (pH 7.4) in 
the absence or presence of DPC (0.35%, Anatrace), DDM (0.05%, 
Anatrace), OG (2%, Sigma-Aldrich), or LDAO (0.05%; Anatrace). 
Spectra were recorded from 260 to 190 nm with a data pitch and 
bandwidth of 1 nm and a scan speed of 100 nm/min. An average of 
three runs was recorded for each peptide sample. Fraction helicity 
(%) was calculated by (%) = 100(([]222 − []coil) / (−42,500(1 − 
(3/n) − []coil)), where []coil = 640 − 45 T = −260° cm2 dmol−1 res−1 
at 20°C and n is the number of peptide bonds (64).
NMR spectroscopy
1D proton spectra of free KLC1D/E synthetic peptide titrated with 
increasing concentrations of DPC were acquired at ∼300 mM in 
PBS buffer supplemented with 10% D2O at 298 K. The DPC-bound 
peptide sample was prepared by dissolving lyophilized peptide in 
PBS supplemented with 7% D2O with 0.7% perdeuterated d38-DPC 
(Cambridge Isotope Laboratories) at a final concentration of ~2 mM. 
Standard 2D NMR spectra [NOESY, TOCSY, correlation spectros-
copy (COSY), 1H-15N HSQC, and 1H-13C HSQC] were acquired 
at 298 K. NOESY spectra had mixing times of 80, 120, and 250 ms. 
To guide assignment of the bound peptide, standard 2D NMR spectra 
(NOESY, TOCSY, COSY, 1H-15N HSQC and 1H-13C HSQC) 
were also acquired for the free peptide at 278 K. The signals of the 
free peptide at the lower temperature were better dispersed and 
sharper than at 298 K, allowing partially assignment (fig. S5C). All 
data were collected on a Bruker Avance III HD 700-MHz spectrometer 
(Bruker, MA, USA) equipped with a 1.7-mm inverse triple resonance 
micro-cryoprobe using standard pulse sequences from the Bruker 
library. NMR data were processed in NMRPipe (65) or TopSpin 3.6 
and analyzed using CCPNMR analysis v 2.4.2 (66). Dextran sulfate 
sodium was used as a chemical shift standard.
Liposome preparation and cosedimentation assays
The appropriate lipids were mixed in organic solution, and the 
solvent was evaporated to dryness under an N2 stream. The sample 
was then kept under N2 stream for an additional 30 min to remove 
solvent traces. The lipids were swollen in 25 mM Hepes (pH 7.4), 
150 mM NaCl, and 1 mM DTT (Sigma-Aldrich) to obtain multi-
lamellar vesicles (MLVs) at 1 mg/ml. LUVs were prepared from 
MLVs. They were subjected to 10 freeze/thaw cycles and then ex-
truded using 0.2-m pore size Nuclepore filters (Whatman). SUVs 
were obtained by sonicating MLVs with a probe tip sonicator (MSE 
Soniprep 150, MSE, UK) for 10 min (10 s on, 10 s off) on ice. For 
cosedimentation assays, 43 g (unless otherwise specified) of lipo-
somes was incubated with 5 or 0.2 M of the indicated KLCCTD or 
tetra meric kinesin-1, respectively (100 l, final volume), for 30 min 
and spun down at 170,000g in a Beckman TLA-100 rotor. Supernatant 
and pellet fractions were collected and analyzed by SDS-PAGE and 
Coomassie stain.
PIP arrays
PIP arrays (Echelon Biosciences) were used according to the manu-
facturer’s instructions. Briefly, strips were blocked with 3% fatty acid–
free BSA (Sigma-Aldrich) in PBS buffer containing 0.1% Tween 20 
overnight at 4°C before incubation with the indicated protein (1 g/ml) 
for 1 hour at room temperature. PIP strips were rinsed thoroughly, 
and protein binding was visualized using an HRP-conjugated anti-His 
antibody and enhanced chemiluminiscence reagents (Geneflow). 
Spot intensities were detected on films (GE Healthcare).
BS3 cross-linking assays
BS3 cross-linker (2 mg; Thermo Fisher Scientific) was dissolved in 
Milli-Q water immediately before use, and 0 to 2 mM were added to 
the corresponding sample. The reaction mixture was incubated at 
room temperature for 30 min before quenching with SDS sample 
buffer for an additional 15 min. Samples were heated at 95°C for 
10 min followed by SDS-PAGE analysis.
Cryo–electron microscopy
Forty-three micrograms of liposomes was incubated in the presence 
or absence of 5 M His-KLC1ECTD for 30 min. Lacey carbon film 
grids (EM Resolutions) were glow-discharged for 30 s in a Leica 
ACE 600 Coater system (Leica Microsystems, Heidelberg, Germany). 
Five microliters of sample was pipetted onto the grids, and the sample 
was plunge-frozen in liquid ethane using a Leica GP Plunge freezing 
device (Leica Microsystems, Heidelberg, Germany). The grids were 
then transferred under liquid nitrogen into a Gatan 626 Cryotransfer 
system (Gatan, CA, USA) and imaged at ≤−170°C in a FEI Tecnai 
20 LaB6 Scanning Transmission Electron Microscope (FEI, OR, USA) 
operating at 200 kV and using low-dose imaging conditions. Images 
were acquired on a FEI CETA 16 M complementary metal-oxide 
semiconductor camera (FEI, OR, USA).
Cell culture, transfection, and immunoblotting
HeLa and 293T cells were grown in high-glucose Dulbecco’s modi-
fied Eagle’s medium (DMEM; Sigma-Aldrich) supplemented with 
10% fetal bovine serum (FBS; Sigma-Aldrich) and 1% penicillin/
streptomycin (Gibco) at 37°C with 5% CO2. HeLa transient transfec-
tions were performed using Effectene transfection reagent (QIAGEN) 
according to the manufacturer’s instructions. The efficacy of cell 
transfection was checked using fluorescence microscopy or Western 
blotting. For immunoblotting, cells grown on six-well plates were 
initially washed with ice-cold PBS and then lysed with ice-cold 
radioimmunoprecipitation assay (100 l per well) buffer consisting 
of 50 mM Hepes (pH7.5), 150 mM NaCl, 0.1% NP40, 0.5% sodium 
deoxycholate, and 0.1% SDS supplemented with protease inhibitor 
cocktail. The homogenates were incubated on ice for 15 min and 
then cleared by centrifugation at 12,000g for 15 min at 4°C. Super-
natants were collected as soluble fractions. Protein samples were 
resolved on NuPAGE 4 to 12% precast gels (Invitrogen), transferred 
onto polyvinylidene difluoride membranes, blocked in 5% milk in 
TBS-T [20 mM tris, 0.25 M NaCl, and 0.1% Tween-20 (pH 7.5) with 
HCl], and probed with the indicated primary and secondary anti-
bodies (listed above) followed by detection using the Odyssey Infrared 
Scanning System (LI-COR Biosciences).
Immunofluorescence and cell imaging
HeLa cells were seeded on coverslips in six-well plates before trans-
fection. Twenty-four hours after transfection, cells were fixed with 
4% formaldehyde (Thermo Fisher Scientific) for 15 min or ice-cold 
methanol for 5 min. Fixed cells were blocked in 3% BSA and 1% fetal 
calf serum (Sigma-Aldrich) buffer and incubated for 30 min 
with primary and secondary antibodies (listed above) diluted in 
blocking buffer. Cells were 4′,6-diamidino-2-phenylindole–stained 
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(Thermo Fisher Scientific) and placed cell side down in FluorSave 
reagent (Calbiochem). Confocal microscopy was carried out using 
a Leica SP5-AOBS confocal laser scanning microscope attached 
to a Leica DM I6000 inverted epifluorescence microscope (Leica 
Microsystems, Heidelberg, Germany). A 63×, 1.4 numerical aperture 
oil immersion objective (Plan Apochromat BL; Leica Biosystems) 
and the standard SP5 system acquisition software and detector were 
used. Image analysis was performed using ImageJ. For colocalization 
studies, Pearson’s correlation coefficient was calculated from ∼40 cells 
per condition using ImageJ.
siRNA transfection
In HeLa cells, siRNA transfection was carried out through reverse 
transfection protocol with HiPerFect (QIAGEN). Six microliters of 
10 M siRNAs targeting human siKLC1 or siKLC2 was mixed with 
12 l of HiPerFect in high-glucose DMEM (Sigma-Aldrich) and 
combined with 1 × 105 cells per well of a six-well plate. Samples were 
collected 72 hours after the transfection. For rescue experiments, 
corresponding mouse KLC1/2 cDNAs (near identical proteins) were 
transiently transfected so that the siRNA would not recognize the 
targeting sequence.
Sequence and secondary structure analysis
Sequence alignment of the KLCCTDs was performed using PROMALS3D 
(67) or Clustal Omega using the MegAlign Pro application of the 
DNASTAR Lasergene suite as indicted. Some alignments were fur-
ther manually edited as indicated in the figure legends. The analysis 
and characterization of the predicted secondary structure were per-
formed using JPred4 (68) and HeliQuest (69). Helical 3D models 
were prepared with PyMol (Schrödinger).
KLC phylogeny
Orthologs from ENSEMBL (PMID 31691826) for KLC1 to KCL4 were 
used as a starting point, followed by sequence similarity searching 
with BLAST to identify KLC homologs in a wider range of species. 
Sequences were aligned using the l-INS-I mode in MAFFT (70), and 
IQ-TREE2 (71) was used to infer phylogenies under the best-fitting 
model, selected by Bayesian information criterion (BIC). An itera-
tive process of tree inference was used to classify homologous se-
quences as orthologs and paralogs and to identify species-specific 
duplications. For the final tree, the best-fit model was JTT + R6 under 
the BIC, Akaike information criterion (AIC), and corrected AIC 
(AICc) criteria.
Statistical analysis
Data are presented as means ± SEM and were analyzed by t test using 
Prism 8 (GraphPad Software, CA); *P < 0.05, **P < 0.01, and ***P < 0.001.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/31/eabg6636/DC1
View/request a protocol for this paper from Bio-protocol.
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